Literature DB >> 26770164

Research Battles: Survival Tips From a Veteran.

Linda L Isaacs1.   

Abstract

Studies of nonorthodox medical treatments may go awry because of inherent flaws in designs that are better suited for trials of pharmaceutical products. Unintended consequences may follow from efforts at randomization, the lack of lead-in periods, required visits for medical assessment, inadequate screening, and a lack of trial publicity. A veteran of a mismanaged trial shares her experiences.

Year:  2015        PMID: 26770164      PMCID: PMC4712871     

Source DB:  PubMed          Journal:  Integr Med (Encinitas)        ISSN: 1546-993X


  4 in total

1.  Evaluation of pancreatic proteolytic enzyme treatment of adenocarcinoma of the pancreas, with nutrition and detoxification support.

Authors:  N J Gonzalez; L L Isaacs
Journal:  Nutr Cancer       Date:  1999       Impact factor: 2.900

2.  Pancreatic enzyme extract improves survival in murine pancreatic cancer.

Authors:  Murat Saruc; Silke Standop; Jens Standop; Fumiaki Nozawa; Atsushi Itami; Krishan K Pandey; Surinder K Batra; Nicholas J Gonzalez; Pierre Guesry; Parviz M Pour
Journal:  Pancreas       Date:  2004-05       Impact factor: 3.327

3.  Pancreatic proteolytic enzyme therapy compared with gemcitabine-based chemotherapy for the treatment of pancreatic cancer.

Authors:  John A Chabot; Wei-Yann Tsai; Robert L Fine; Chunxia Chen; Carolyn K Kumah; Karen A Antman; Victor R Grann
Journal:  J Clin Oncol       Date:  2009-08-17       Impact factor: 44.544

4.  The diabetes control and complications trial (DCCT): the trial coordinator perspective. Report by the DCCT Research Group.

Authors:  J A Ahern; D F Kruger; P M Gatcomb; W A Petit; W V Tamborlane
Journal:  Diabetes Educ       Date:  1989 May-Jun       Impact factor: 2.140

  4 in total
  1 in total

Review 1.  Pancreatic Proteolytic Enzymes and Cancer: New Support for an Old Theory.

Authors:  Linda L Isaacs
Journal:  Integr Cancer Ther       Date:  2022 Jan-Dec       Impact factor: 3.077

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.